Identification of disulfiram as a secretase-modulating compound with beneficial effects on Alzheimer’s disease hallmarks
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of disulfiram as a secretase-modulating compound with beneficial effects on Alzheimer’s disease hallmarks
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-01-16
DOI
10.1038/s41598-018-19577-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cooperative Therapeutic Action of Retinoic Acid Receptor and Retinoid X Receptor Agonists in a Mouse Model of Alzheimer's Disease
- (2018) Kohichi Kawahara et al. JOURNAL OF ALZHEIMERS DISEASE
- Design, synthesis and evaluation of scutellarein- O -acetamidoalkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer's disease
- (2017) Zhipei Sang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The discovery of Alzheimer-causing mutations in the APP gene and the formulation of the “amyloid cascade hypothesis”
- (2017) John Hardy FEBS Journal
- Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends
- (2017) Sergey O. Bachurin et al. MEDICINAL RESEARCH REVIEWS
- Poly lactic-co-glycolic acid controlled delivery of disulfiram to target liver cancer stem-like cells
- (2017) Zhipeng Wang et al. Nanomedicine-Nanotechnology Biology and Medicine
- Regulation of Alpha-Secretase ADAM10 In vitro and In vivo: Genetic, Epigenetic, and Protein-Based Mechanisms
- (2017) Kristina Endres et al. Frontiers in Molecular Neuroscience
- Disulfiram Induced Psychosis
- (2017) Satyakam Mohapatra et al. Clinical Psychopharmacology and Neuroscience
- Molecular mechanism of prion-like tau-induced neurodegeneration
- (2016) Alejandra D. Alonso et al. Alzheimers & Dementia
- An Ophthalmic Formulation of Disulfiram Nanoparticles Prolongs Drug Residence Time in Lens
- (2016) Noriaki Nagai et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Transnasal delivery of human A-beta peptides elicits impaired learning and memory performance in wild type mice
- (2016) Kristina Endres et al. BMC NEUROSCIENCE
- Molecular Basis of Familial and Sporadic Alzheimer's Disease
- (2016) Jolanta Dorszewska et al. Current Alzheimer Research
- Alzheimer's disease: Targeting the Cholinergic System
- (2016) Talita H. Ferreira-Vieira et al. Current Neuropharmacology
- Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease
- (2016) Mercedes Unzeta et al. Frontiers in Neuroscience
- N-Acetyl-S-(N,N-diethylcarbamoyl) cysteine in rat nucleus accumbens, medial prefrontal cortex, and in rat and human plasma after disulfiram administration
- (2015) Robert D. Winefield et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Extract of Caragana sinica as a potential therapeutic option for increasing alpha-secretase gene expression
- (2015) Florian Schuck et al. PHYTOMEDICINE
- Acitretin in psoriasis: an evolving scenario
- (2014) Sunil Dogra et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects
- (2014) Robert Vassar et al. JOURNAL OF NEUROCHEMISTRY
- Increased CSF APPs- levels in patients with Alzheimer disease treated with acitretin
- (2014) K. Endres et al. NEUROLOGY
- Drug Repositioning Approaches for the Discovery of New Therapeutics for Alzheimer’s Disease
- (2014) Tae-Wan Kim Neurotherapeutics
- Holo-APP and G-protein-mediated signaling are required for sAPPα-induced activation of the Akt survival pathway
- (2014) N Milosch et al. Cell Death & Disease
- Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's disease
- (2013) Sven Reinhardt et al. FASEB JOURNAL
- Dopamine D2 Receptor-mediated Epidermal Growth Factor Receptor Transactivation through a Disintegrin and Metalloprotease Regulates Dopaminergic Neuron Development via Extracellular Signal-related Kinase Activation
- (2013) Sehyoun Yoon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Excessive hydrogen peroxide enhances the attachment of amyloid β1–42 in the lens epithelium of UPL rats, a hereditary model for cataracts
- (2013) Noriaki Nagai et al. TOXICOLOGY
- Thioredoxin-80 is a product of alpha-secretase cleavage that inhibits amyloid-beta aggregation and is decreased in Alzheimer's disease brain
- (2012) Francisco Gil-Bea et al. EMBO Molecular Medicine
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Altering APP Proteolysis: Increasing sAPPalpha Production by Targeting Dimerization of the APP Ectodomain
- (2012) Clare A. Peters Libeu et al. PLoS One
- The cholinergic system in aging and neuronal degeneration
- (2010) Reinhard Schliebs et al. BEHAVIOURAL BRAIN RESEARCH
- ADAM10 is the physiologically relevant, constitutive α-secretase of the amyloid precursor protein in primary neurons
- (2010) Peer-Hendrik Kuhn et al. EMBO JOURNAL
- The Disintegrin/Metalloproteinase ADAM10 Is Essential for the Establishment of the Brain Cortex
- (2010) E. Jorissen et al. JOURNAL OF NEUROSCIENCE
- Oral Administration of Synthetic Retinoid Am80 (Tamibarotene) Decreases Brain β-Amyloid Peptides in APP23 Mice
- (2009) Kohichi Kawahara et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Identification of ADAM10 as a major TNF sheddase in ADAM17-deficient fibroblasts
- (2009) Renata Mężyk-Kopeć et al. CYTOKINE
- Up-regulation of the α-secretase ADAM10 by retinoic acid receptors and acitretin
- (2009) Frank Tippmann et al. FASEB JOURNAL
- Dose translation from animal to human studies revisited
- (2007) Shannon Reagan-Shaw et al. FASEB JOURNAL
- ADAM-10 over-expression increases cortical synaptogenesis
- (2006) Karen F.S. Bell et al. NEUROBIOLOGY OF AGING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation